Novavax Nuvaxovid COVID-19 vaccine conditionally authorized in EU for adolescents aged 12 through 17
On Jul. 13, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
U.S. FDA granted EUA for Novavax COVID-19 vaccine, adjuvanted for individuals aged 18 and over
On Jul. 13, 2022, Novavax announced that its COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received emergency use authorization from…
Quest Diagnostics launched Monkeypox virus testing
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
Moderna’s Omicron-containing bivalent booster candidate, mRNA-1273.214, demonstrated higher neutralizing antibody response
On Jul. 11, 2022, Moderna announced new clinical data on its bivalent Omicron (BA.1) booster candidate, mRNA-1273.214. One…
COVID-19 | NIH | Therapeutics | Vaccine
U.S. Government secured 3.2 million doses of Novavax COVID-19 vaccine
On Jul. 11, 2022, Novavax announced an agreement with the U.S. Department of Health and Human Services (HHS),…
NIH launched clinical trial of mRNA Nipah virus vaccine
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
Pfizer and BioNTech submitted a variation to EMA for vaccination of children ages 6 months to less than 5 Years with COMIRNATY
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
Fourth backyard flock tested positive for highly pathogenic avian influenza in Oregon
On Jul. 8, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service confirmed the state’s…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA confirmed highly pathogenic Avian influenza in Nevada
On Jul. 8, 2022, the U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
Ghana reported first-ever suspected cases of Marburg virus disease
On Jul. 7, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
European Medicines Agency approved SK bioscience as supplier of Novavax Nuvaxovid COVID-19 vaccine
On Jul. 7, 2022, Novavax announced that the European Commission had approved a variation to allow SK bioscience…
Labcorp first national laboratory to offer Monkeypox test
On Jul. 6, 2022, LabCorp announced that it had begun testing for monkeypox using the U.S. Centers for…
Novavax Nuvaxovid COVID-19 vaccine conditionally authorized in EU for adolescents aged 12 through 17
On Jul. 5, 2022, Novavax announced that the European Commission (EC) had approved the expanded conditional marketing authorization…
COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
On Jul. 5, 2022, the National Institutes of Health and National Cancer Institute announced COVID-19 was the third…
NIH study revealed how immune response triggered by COVID-19 may damage the brain
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
The Democratic Republic of the Congo declareed 14th Ebola outbreak over
On Jul. 4, 2022, the Democratic Republic of the Congo declared the end of the Ebola outbreak that…
Pfizer announced submission of New Drug Application to the U.S. FDA for PAXLOVID
On Jun. 30 2022, Pfizer announced the submission of a New Drug Application (NDA) to the U.S. Food…
Pfizer and BioNTech announced agreement with U.S. Government to provide additional doses of COVID-19 Vaccine
On Jun. 30, 2022, Pfizer and BioNTech announced a vaccine supply agreement with the U.S. government to support…
BD launched combination test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
On Jun. 30, 2022, BD (Becton, Dickinson) announced that the BD MAX Respiratory Viral Panel (RVP), a new…
Trial of potential universal flu vaccine opened at NIH Clinical Center
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Disease | FDA | Life Science History | Medicine | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 Wheel of Fortune
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
Pfizer and BioNTech announced Omicron-adapted COVID-19 vaccine candidates demonstrated high immune response
On Jun. 24 2022, Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two…
Emergent BioSolutions announced FDA acceptance of Biologics License Application for AV7909 Anthrax vaccine candidate
On Jun. 24, 2022, Emergent BioSolutions announced that the U.S. Food and Drug Administration accepted for review the…
Novavax filed supplement to a New Drug submission in Canada for Nuvaxovid COVID-19 vaccine for adolescents
On Jun. 23 2022, Novavax announced the filing of a Supplement to a New Drug Submission with Health…
Novavax COVID-19 vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents aged 12 through 17
On Jun. 23 2022, Novavax announced that the Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional…
Novavax COVID-19 vaccine Nuvaxovid received EUA in Taiwan for use in individuals aged 18 and over
On Jun. 23 2022, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
BioNTech started construction of first mRNA vaccine manufacturing facility in Africa
On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine…
Innovation Pharmaceuticals reported Brilacidin inhibited Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants
On Jun. 23, 2022, Innovation Pharmaceuticals reported that Brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral activity,…
U.S. FDA approved Merck’s VAXNEUVANCE for prevention of invasive pneumococcal disease in infants and children
On Jun. 22, 2022, Merck announced that that the U.S. Food and Drug Administration (FDA) had approved an…